Pharmaceutics (Aug 2024)

Antibiofilm and Antihemolytic Activities of <i>Actinostemma lobatum</i> Extract Rich in Quercetin against <i>Staphylococcus aureus</i>

  • Jin-Hyung Lee,
  • Yong-Guy Kim,
  • Ji-Su Choi,
  • Yong Tae Jeong,
  • Buyng Su Hwang,
  • Jintae Lee

DOI
https://doi.org/10.3390/pharmaceutics16081075
Journal volume & issue
Vol. 16, no. 8
p. 1075

Abstract

Read online

Staphylococcus aureus biofilm formation is a pivotal mechanism in the development of drug resistance, conferring resilience against conventional antibiotics. This study investigates the inhibitory effects of Actinostemma lobatum (A. lobatum) Maxim extracts on S. aureus biofilm formation and their antihemolytic activities, with a particular focus on identifying the active antibiofilm and antihemolysis compound, quercetin. Seven solvent extracts and twelve sub-fractions were evaluated against four S. aureus strains. The ethyl acetate fraction (10 to 100 μg/mL) significantly hindered biofilm formation by both methicillin-sensitive and -resistant strains. Bioassay-guided isolation of the ethyl acetate extract identified quercetin as the major antibiofilm compound. The ethyl acetate extract was found to contain 391 μg/mg of quercetin and 30 μg/mg of kaempferol. Additionally, the A. lobatum extract exhibited antihemolytic activity attributable to the presence of quercetin. The findings suggest that quercetin-rich extracts from A. lobatum and other quercetin-rich foods and plants hold promise for inhibiting resilient S. aureus biofilm formation and attenuating its virulence.

Keywords